Top 12 Emerging Gene and Cell Therapy Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham

Disruptive Dozen

Breakthroughs range from restoration of sight and increasing the supply of donor organs, to treating brain cancer, hearing loss, and autoimmune diseases BOSTON, MA – May 4, 2022 — Mass General Brigham today revealed the annual “Disruptive Dozen,” 12 emerging gene and cell therapy (GCT) technologies with the greatest potential to impact health care in…

Read More

Breaking the Code: Diagnostic and Therapeutic Potential of RNA


Ribonucleic acid, or RNA, is one of the three major biological macromolecules that are, along with DNA and proteins, essential for all known forms of life. Recently, types of RNA called microRNAs (miRNA) and long-non-coding RNAs (lncRNAs) have been found to play important roles in gene regulation, capturing international scientific attention for their potential as…

Read More